CMP-001
CMP-001-002
Phase 1 small_molecule completed
Quick answer
CMP-001 for Malignant Melanoma is a Phase 1 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Malignant Melanoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed